Back to results
US 2002/0177623 A1Published application
Use of (Z) -2-cyano-3-hydroxy-but-2-enoic acid-(4' -trifluoromethylphenyl)-amide for treating multiple sclerosis
AssigneeAventis Pharmaceuticals Inc.
InventorJoseph Wettstein
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of compound of Formula I in treating patients for the symptoms of multiple sclerosis. 1
Claims1
A method of treating multiple sclerosis which comprises administering to a patient having multiple sclerosis a therapeutically effective amount of a compound of Formula I, its stereoisomer, or a pharmaceutically acceptable salt thereof,
- 5
Dependencies are inferred from the claim text.